JBM  Vol.5 No.3 , March 2017
Atopic Dermatitis Deteriorates Dextran Sodium Sulfate-Induced Ulcerative Colitis via Thymic Stromal Lymphopoietin in Mice
Abstract: It has been reported that atopic dermatitis (AD) and ulcerative colitis are related. However, the mechanism underlying this association has not been clarified. We therefore explored how AD induces ulcerative colitis. We developed an AD mouse model (NC/Nga mice) with ulcerative colitis by administering dextran sodium sulfate (DSS) for five days. DSS-induced ulcerative colitis was deteriorated in our conventional AD mouse model compared with specific-pathogen-free (SPF) mice. The plasma levels of thymic stromal lymphopoietin (TSLP) and tumor necrosis factor-α increased the most in DSS-treated conventional mice. Furthermore, the expression of dendritic cells (DC), retinoid-related orphan receptor (ROR)γt (marker of T helper 17 cells [Th17]), interleukin (IL)-17, GATA binding protein 3 (GATA3) (marker of Th2), and IL-4 increased the most in the colon of the DSS-treated conventional mice compared with DSS-treated SPF mice. In addition, TSLP inhibitor (TSLP neutralizing antibody) did not exacerbate ulcerative colitis in DSS-treated conventional mice. These results indicate that TSLP/DC/Th2 and Th17 play major roles in the exacerbation of ulcerative colitis by AD.
Cite this paper: Hiramoto, K. , Orita, K. , Yamate, Y. and Yokoyama, S. (2017) Atopic Dermatitis Deteriorates Dextran Sodium Sulfate-Induced Ulcerative Colitis via Thymic Stromal Lymphopoietin in Mice. Journal of Biosciences and Medicines, 5, 85-98. doi: 10.4236/jbm.2017.53009.

[1]   Dilawari, J.B., Parkinson, C., Riddell, R.H., Loose, H. and Williams, C. (1973) Colonoscopy in the Investigation of Ulcerative Colitis. Gut, 14, 426.

[2]   Buffinton, G.D. and Doe, W.F. (1995) Altered Ascorbic Acid Status in the Mucosa from Inflammatory Bowel Disease Patients. Free Radical Research, 22, 131-143.

[3]   Kullmann, F., Messmann, H., Alt, M., Gross, V., Bocker, T., Scholmerich, J. and Ruschoff, J. (2001) Clinical and Histopathological Features of Dextran Sulfate Sodium Induced Acute and Chronic Colitis Associated with Dysplasia in Rats. International Journal of Colorectal Disease, 16, 238-246.

[4]   Fan, Y. and Liu, B. (2015) Expression of Toll-Like Receptors in the Mucosa of Patients with Ulcerative Colitis. Experimental and Therapeutic Medicine, 9, 1455-1459.

[5]   Bar-On, L., Zigmond, E and Jung, S. (2011) Management of Gut Inflammation through the Manipulation of Intestinal Dendritic Cells and Macrophages? Seminars in Immunology, 23, 58-64.

[6]   Ohkusa, T. and Koido, S. (2015) Intestinal Microbiota and Ulcerative Colitis. Journal of Infection and Chemotherapy, 21, 761-768.

[7]   Iglesias-Rey, M., Barreiro-de Acosta, M, Caamano-Isorna, F., Rodriguez, I.V., Ferreiro, R., Lindkvist, B., Gonzalez, A.L. and Dominguez-Munoz, J.E. (2014) Psychological Factors Are Associated with Changes in the Health-Related Quality of Life in Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 20, 92-102.

[8]   Japanese Dermatological Association Atopic-Dermatitis Clinical Practice Guideline Creation Committee (2016) Atopic Dermatitis Clinical Practice Guideline 2016. Japanese Journal of Dermatology, 126, 121-155.

[9]   Palmer, C.N., Irvine, A.D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S.P., Goudie, D.R., Sandilands, A., Campbell, L.E., Smith, F.J., O’Regan, G.M., Watson, R.M., Cecil, J.E., Bale, S.J., Compton, J.G., DiGiovanna, J.J., Fleckman, P., Lewis-Jones, S., Arseculeratne, G., Sergeant, A., Munro, C.S., El Houate, B., McElreavey, K., Halkjaer, L.B., Bisgaard, H., Mukhopadhyay, S. and McLean, W.H. (2006) Common Loss-of-Function Variants of the Epidermal Barrier Protein Filaggrin Are a Major Predisposing Factor for Atopic Dermatitis. Nature Genetics, 38, 441-446.

[10]   Nakajima, S., Igyarto, B.Z., Honda, T., Egawa, G., Otsuka, A., Hara-Chikuma, M., Watanabe, N., Ziegler, S.F., Tomura, M., Inaba, K., Miyachi, Y., Kaplan, D.H. and Kabashima, K. (2012) Langerhans Cells Are Critical in Epicutaneous Sensitization with Protein Antigen via Thymic Stromal Lymphopoietin Receptor Signaling. Journal of Allergy and Clinical Immunology, 129, 1048-1055.

[11]   Otuka, A., Nakajima, A., Kubo, M., Wgawa, G., Honda, T., Kitoh, A., Nomura, T., Hanakawa, S., SagitaMoniaga, C., Kim, B., Matsuoka, S., Watanabe, T., Miyachi, Y. and Kabashima, K. (2013) Basophils Are Required for the Induction of Th2 Immunity to Haptens and Peptide Antigens. Nature Communications, 4, Article No. 1738.

[12]   Kato, A., Fujii, E., Watanabe, T., Takashima, Y., Matsushita, H., Furuhashi, T. and Morita, A. (2014) Distribution of IL-13 and Its Receptor Expressing Cells in Skin of Atopic Dermatitis. Journal of Dermatological Science, 74, 229-235.

[13]   Schmitt, J., Schwarz, K., Baurecht, H., Hotze, M., Folster-Holst, R., Rodriguez, E., Lee, Y.A., Franke, A., Degenhardt, F., Lieb, W., Gieger, C., Kabesch, M., Nothen, M.M., Irvine, A.D., McLean, W.H., Deckert, S., Stephan, V., Schwarz, P., Aringer, M., Novak, N. and Weidinger, S. (2016) Atopic Dermatitis Is Associated with an Increased Risk for Rheumatoid Arthritis and Inflammatory Bowel Disease, and a Decreased Risk for Type 1 Diabetes. Journal of Allergy and Clinical Immunology, 137, 130-136.

[14]   Boneberger, A., Weiss, E.H., Calvo, M. and Radon, K. (2012) Atopic Manifestations in Patients with Ulcerative Colitis: A Report from Chile. Journal of Investigational Allergology and Clinical Immunology, 22, 73-75.

[15]   Dahten, A., Koch, C., Ernst, D., Schnoller, C., Hartmann, S. and Worm, M. (2008) Systemic PPARγ Ligation Inhibits Allergic Immune Response in the Skin. Journal of Investigative Dermatology, 128, 2211-2218.

[16]   Nishimura, T., Andoh, A., Hashimoto, T., Kobori, A., Tsujikawa, T. and Fujiyama, Y. (2010) Cellobiose Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis. Journal of Clinical Biochemistry and Nutrition, 46, 105-110.

[17]   Park, L.S., Martin, U., Garka, K., Gliniak, B., Di Santo, J.P., Muller, W., Largaespada, D.A., Copeland, N.G., Jenkins, N.A., Farr, A.G., Ziegler, S.E., Morrissey, P.J., Paxton, R. and Sims, J.E. (2000) Cloning of the Murine Thymic Stromal Lymphopoietin (TSLP) Receptor. Journal of Experimental Medicine, 192, 659-669.

[18]   Yokoyama, S., Hiramoto, K., Koyama, M. and Ooi, K. (2014) Skin Disruption Is Associated with Indomethacin-Induced Small Intestinal Injury in Mice. Experimental Dermatology, 23, 659-663.

[19]   Hiramoto, K., Sugiyama, D., Takahashi, Y. and Mafune, E. (2016) The Amelioration Effect of Tranexamic Acid in Wrinkles Induced by Skin Dryness. Biomedicine & Pharmacotherapy, 80, 16-22.

[20]   Onodera, A., Yamashita, M., Endo, Y., Kawahara, M., Tofukuji, S., Hosokawa, H., Kanai, A., Suzuki, Y. and Nakayama, T. (2010) STAT6-Mediated Displacement of Polycomb by Trithorax Complex Establishes Long-Term Maintenance of GATA3 Expression in T Helper Type 2 Cells. Journal of Experimental Medicine, 207, 2493-2506.

[21]   Korn, T., Bettelli, E., Oukka, M. and Kuchroo, V.K. (2009) IL-17 and Th17 Cells. Annual Review of Immunology, 27, 485-517.

[22]   Elson, C.O., Sarton, R.B., Tennyson, G.S. and Riddell, R.H. (1995) Experimental Models of Inflammatory Bowel Disease. Gastroenterology, 109, 1344-1367.

[23]   Komekura, R., Kojima, T., Koizumi, J., Ogasawara, N., Kurose, M., Go, M., Harimaya, A., Murata, M., Tanaka, S., Chiba, H., Himi, T and Sawada, N. (2009) Thymic Stromal Lymphopoietin Enhances Tight-Junction Barrier Function of Humannosal Epithelial Cells. Cell and Tissue Research, 338, 283-293.

[24]   Liu, Y.J., Soumelis, V., Watanabe, N., Ito, T., Wang, Y.H., MalefytRde, W., Omori, M., Zhou, B. and Ziegler, S.F. (2007) TSLP: An Epithelial Cell Cytokine That Regulates T Cell Differentiation by Conditioning Dengritic Cell Maturation. Annual Review Immunology, 25, 193-219.

[25]   Allakhverdi, Z., Comeau, M.R., Jessup, H.K., Yoon, B.R., Brewer, A., Chartier, S., Paquette, N., Ziegler, S.F., Sarfati, M. and Delespesse, G. (2007) Thymic Stromal Lymphopoietin Is Released by Human Epithelial Cells in Response to Microbes, Trauma, or Inflammation and Potently Activates Mast Cells. Journal of Experimental Medicine, 204, 253-258.

[26]   Nagata, Y., Kamijuku, H., Taniguchi, M., Ziegler, S. and Seino, K. (2007) Differential Role of Thymic Stromal Lymphopoietin in the Induction of Airway Hyperreactivity and Th2 Immune Response in Antigen-Induced Asthma with Respect to Natural Killer T Cell Function. International Archives of Allergy and Immunology, 144, 305-314.

[27]   Kitajima, M., Lee, H.C., Nakayama, T. and Ziegler, S.F. (2011) TSLP Enhances the Function of Helper Type 2 Cells. European Journal of Immunology, 41, 1862-1871.

[28]   Bell, B.D., Kitajima, M., Larson, R.P., Stoklasek, T.A., Dang, K., Sakamoto, KG., Wagner, K.U., Kaplan, D.H., Reizis, B., Hennighausen, LH. and Ziegler, S.F. (2013) The Transcription Factor SRAT5 Is Critical in Dendritic Cells for the Development of TH2 but Not TH1 Responses. Nature Immunology, 14, 364-371.

[29]   Tezuka, H. and Ohteki, T. (2010) Regulation of Intestinal Homeostasis by Dendritic Cells. Immunological Reviews, 234, 247-258.

[30]   He, R. and Geha, R.S. (2010) Thymic Stromal Lymphopoietin. Annals of the New York Academy of Sciences, 1183, 13-24.

[31]   Li, J., Leyva-Castillo, J.M., Hener, P., Eisenmamm, A., Zaafouri, S., Jonca, N., Serre, G., Birling, M.C. and Li, M. (2016) Counterregulation between Thymic Stromal Lymphopoietin- and IL-23-Driven Immune Axes Shapes Skin Inflammation in Mice with Epidermal Barrier Defects. Journal of Allergy and Clinical Immunology, 138, 150-161.

[32]   Spadoni, I., Iliev, I.D., Rossi, G. and Rescigno, M. (2012) Dendritic Cells Produce TSLP That Limits the Differentiation of Th17 Cells, Fosters Treg Development, and Protects against Colitis. Mucosal Immunology, 5, 184-193.

[33]   Yamamoto, T., Endo, Y. and Nakayama, T. (2016) Innate Immunity. Japanese Journal of Allergology, 65, 1-10.